BridgeBio has significantly advanced the progress of a innovative treatment for ATTR-CM, employing Attruby. Early trial information indicates potential improvements for individuals suffering with a serious illness. This https://biotech687945.estate-blog.com/40906999/bridgebio-advances-cardiac-amyloidosis-management-using-the-therapy